1,580 material Form 8-K filings that 1,317 companies we cover made with the SEC in July 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
A Delaware Court of Chancery approved on June 30, 2026 a settlement of the Dollens shareholder lawsuit, and on July 8, 2026 Goosehead and its pre-IPO stockholders signed an Amended and Restated Stockholders Agreement. While those holders own at least 10% of common shares, they must approve certain major corporate actions and may nominate a majority of the board, including the Chairman, which gives them more influence over governance than other common stockholders have.
On June 30, 2026, the Court of Chancery of the State of Delaware approved the settlement of the Dollens Action (C.A. No. 2022-1018-JTL).
The A&R Stockholders Agreement, dated July 8, 2026, applies while pre-IPO holders beneficially own at least 10% of outstanding common stock.
Pre-IPO holders must approve mergers or sales of substantially all assets, asset deals above 15% of total assets, equity issuances above $50 million, charter amendments, and changes to board size.
Pre-IPO holders may nominate a majority of the board, including the Chairman, but the board need not endorse those nominees if its fiduciary duties require otherwise.
IGC Pharma furnished an updated investor presentation dated July 2026 under Regulation FD, filed as Exhibit 99.1 to a Form 8-K dated July 13, 2026. The presentation covers the Phase 2 CALMA trial of IGC-AD1 for agitation in Alzheimer's dementia, which the filing describes as investigational and not approved by the FDA, and it presents illustrative valuation scenarios that the company says are hypothetical and not forecasts.
The CALMA Phase 2 trial has a target of 146 participants, and the presentation says more than 80% have completed dosing.
The presentation cites a current valuation of about $30 million as of July 10, 2026, with illustrative post-Phase 2 scenarios of $350 million to $750 million over 4 to 9 months.
Blinded pooled data show a mean change in CMAI of −13.6 at week 2 and −14.9 at week 6, which the company says cannot establish treatment effect or efficacy.
Talos Energy's subsidiary Talos Production issued $800 million of 8.000% second-priority senior secured notes due 2034 on July 13, 2026, and used proceeds to help fund its pending purchase of Gulf of America oil and gas assets and to redeem its 9.000% notes due 2029. The new debt adds to the company's borrowings, and $175 million of the notes must be redeemed if the acquisition does not close by December 31, 2026, or if BP exercises a preferential right.
$800 million principal of 8.000% notes due July 15, 2034, with semi-annual interest starting January 15, 2027
Proceeds fund part of the cash price for Gulf of America assets, including Na Kika and Coulomb, under a purchase agreement dated June 30, 2026
$175 million of notes must be redeemed at par plus interest if the acquisition does not close by the December 31, 2026 Outside Date or if BP's preferential right is exercised
Existing 9.000% notes due 2029 were redeemed on July 13, 2026 at 104.500% of principal
CoStar Group appointed Robin Rossmann, its Managing Director, Europe, as Chief Financial Officer effective July 31, 2026. He succeeds Christian Lown, who resigned to pursue an opportunity outside the company's industry, and the company says the resignation was not due to any disagreement on operations, policies or practices. The filing also details Rossmann's pay package, including a $2.5 million equity grant and a $500,000 relocation subsidy.
Robin Rossmann appointed CFO effective July 31, 2026, reporting to Founder and CEO Andy Florance
Christian Lown resigned as CFO effective July 31, 2026; he notified the company on July 7, 2026
Rossmann's base salary is £440,000, rising to $590,000 after relocation to Arlington, VA, with a target bonus of 100% of base salary
One-time equity grant valued at $2.5 million as of July 31, 2026, plus a $500,000 relocation subsidy
Oil States International amended the executive agreement of President and CEO Lloyd A. Hajdik, effective July 9, 2026, restructuring how severance is calculated on certain qualifying termination events. The filing sets out a larger lump sum severance if he is terminated without Cause or resigns for Good Reason within 24 months after a Change of Control, and a smaller lump sum for a no-Cause termination outside that window.
Amendment dated July 9, 2026 to the Executive Agreement originally effective December 9, 2013.
Within 24 months after a Change of Control, a qualifying termination pays a lump sum of 3.0 times Termination Base Salary plus Target AICP.
Outside that 24-month window, a termination without Cause pays a lump sum of 1.5 times Termination Base Salary plus Target AICP.
The filing states all other terms of the Executive Agreement remain in effect; the amendment is filed as Exhibit 10.1.
Brown-Forman said President and CEO Lawson Whiting will retire, effective when a successor is appointed, after nearly 30 years with the company. The board has begun a search for a new CEO, and the company reiterated its fiscal 2027 outlook, first disclosed on June 4, 2026, which means the announcement did not change financial guidance. Leadership transitions can add uncertainty, so shareholders will be watching who is chosen and how the company's strategy continues under new leadership.
Lawson Whiting will retire as President and CEO after nearly 30 years, effective upon the appointment of his successor.
The Corporate Governance and Nominating Committee, chaired by Tracy Skeans, will lead the search, which will consider internal and external candidates.
Whiting will remain available in an advisory capacity for a period after a successor is appointed.
Brown-Forman reiterated its fiscal 2027 outlook, as disclosed on June 4, 2026.
Intapp, Inc. entered a five-year, $150.0 million senior secured revolving credit facility with UBS AG, Stamford Branch as administrative agent, dated July 7, 2026, and terminated its prior credit agreement with JPMorgan Chase Bank, N.A. at the same time. No amounts were outstanding under the new facility at closing, and the filing does not describe any change in the company's operations or results.
Five-year senior secured revolving credit facility of $150.0 million, with a $10.0 million letter of credit subfacility
Borrowings bear interest at Term SOFR plus 1.50% to 2.25%, or an alternate base rate plus 0.50% to 1.25%, based on total net leverage ratio
Facility is secured by substantially all assets (excluding real estate interests) of the company and subsidiary guarantors, and includes a maximum consolidated total net leverage ratio covenant
Prior credit agreement dated October 5, 2021 with JPMorgan Chase Bank, N.A. was terminated concurrently
Franklin Street Properties closed the July 8, 2026 sale of two office buildings at 6550 and 6560 Greenwood Plaza Boulevard in Englewood, Colorado, to University of Colorado Health. The filing's pro forma financials show the sale would have increased the company's reported net loss for 2025, including an estimated loss on sale, though about $8.5 million of proceeds went to debt repayment.
Gross purchase price of $19.4 million for roughly 196,236 square feet, closed July 8, 2026
About $8.5 million of proceeds used to repay debt, including interest and fees; the remainder is retained for tenant improvements, leasing commissions, building improvements and general corporate uses
Pro forma 2025 net loss of $52.7 million ($0.51 per share) versus $45.0 million ($0.43 per share) as reported, reflecting an estimated $7.9 million loss on sale
FB Financial Corporation reported second quarter 2026 net income of $58.6 million, or $1.13 per diluted share, compared with $1.10 in the prior quarter and $0.06 a year earlier, when results included a $60.5 million securities loss. Total revenue rose to $174.8 million and loans held for investment grew to $12.87 billion, while nonperforming loans rose to 1.17% of total loans. The company also repurchased 1,546,707 shares, or 3.01% of shares outstanding, during the quarter.
Net income of $58.6 million, or $1.13 per diluted share, versus $1.10 in Q1 2026 and $0.06 in Q2 2025
Adjusted diluted EPS of $1.14; adjusted pre-tax pre-provision net revenue of $83.6 million
Loans held for investment of $12.87 billion, an 11.6% annualized increase from the prior quarter
Nonperforming loans rose to 1.17% of total loans from 0.96% in the prior quarter, concentrated in three lending relationships
American Shared Hospital Services said its Chief Financial Officer, Raymond S. Frech, resigned effective July 7, 2026, for personal reasons, and that the resignation was not related to any disagreement on accounting policies or practices. The Board named Chief Accounting Officer Alexis N. Tirrito as interim CFO and principal financial and accounting officer, effective immediately, while she keeps her CAO and Secretary roles.
Raymond S. Frech resigned as CFO effective July 7, 2026, for personal reasons; the filing says a severance agreement with customary releases was entered into
Alexis N. Tirrito, CAO and Secretary since October 2021, was appointed interim CFO on July 7, 2026
Tirrito's base salary was set at $240,000, effective July 7, 2026, with a 2026 target bonus of 20% of base salary
ONE Gas expanded its board from eight to nine members on July 13, 2026, appointing Nickolas Stavropoulos, a retired chief operating officer of Pacific Gas & Electric and National Grid, to fill the new seat. The appointment adds an energy industry veteran with more than 40 years of experience to the board, and his director pay is set at a prorated $105,000 retainer plus $140,000 in stock.
Board expanded from eight to nine members; Stavropoulos, 68, appointed effective July 13, 2026
Serves on the Audit, Corporate Governance and Executive Compensation Committees
Annual retainer of $105,000 plus stock retainer valued at $140,000, both prorated through May 19, 2027
Stavropoulos was PG&E chief operating officer from March 2017 to September 2018
On July 10, 2026, Realty Income entered a Fifth Amended and Restated Credit Agreement that raises its unsecured multicurrency revolving credit capacity to $5.5 billion from $4.0 billion, and adds UK and Netherlands subsidiaries as joint borrowers. The company also doubled the maximum outstanding amounts under its U.S. and euro commercial paper programs to $2.75 billion each from $1.50 billion each. The filing says the larger capacity and lower borrowing costs add financial flexibility for shareholders, though the company will carry more borrowing capacity.
Revolving credit capacity rises to $5.5 billion from $4.0 billion, with an accordion feature that can increase it to $6.5 billion subject to lender commitments.
Two $2.75 billion tranches initially mature on April 29, 2029 and July 10, 2030, each with two six-month extension options.
Maximum outstanding commercial paper is $2.75 billion under each of the U.S. and euro programs, up from $1.50 billion each.
The press release cites all-in drawn pricing of 80 basis points over SOFR, a reduction of 5.0 basis points from the prior facilities.
Welltower OP LLC issued C$750 million of 3.850% notes due 2031 and C$400 million of 4.150% notes due 2033 on July 13, 2026, guaranteed by parent Welltower Inc. The company says it will use the proceeds for general corporate purposes, including debt repayment and funding its healthcare and seniors housing investment pipeline.
2031 Notes: C$750 million at 3.850%, maturing August 15, 2031
2033 Notes: C$400 million at 4.150%, maturing August 15, 2033
Interest is paid semiannually from February 15, 2027, and the notes are senior unsecured, guaranteed by Welltower Inc.
Notes were sold under an underwriting agreement dated July 6, 2026, with RBC, Scotia, TD and BMO as representatives
Ceva, Inc. disclosed that Executive Vice President and Chief Operating Officer Michael Boukaya agreed with the company to resign, with his last day as COO set for August 1, 2026. He will stay on as an employee through December 31, 2026 to support a smooth transition.
Resignation agreed mutually between Ceva and Michael Boukaya on July 8, 2026
Last day as Chief Operating Officer is August 1, 2026
Boukaya remains an employee through December 31, 2026 to facilitate the transition
Diamondback Energy disclosed selected second-quarter 2026 operating data: average unhedged oil price of $96.82 per barrel and average hedged oil price of $94.33 per barrel, with natural gas prices negative on both measures. The filing also anticipates a $113 million net cash gain and a $64 million net non-cash loss on derivative instruments, which affect the company's realized results. The filing does not include total revenue, net income, earnings per share or guidance.
Oil: $96.82 per barrel unhedged and $94.33 per barrel hedged in Q2 2026
Natural gas: $(2.15) per Mcf unhedged and $(0.34) per Mcf hedged; NGLs $18.56 per barrel
Anticipated net cash gain on derivative settlements of $113 million and net non-cash loss of $64 million
Basic and diluted weighted average shares outstanding of 281,202 thousand for Q2 2026
Tactile Systems Technology (Tactile Medical) entered an exclusive U.S. distribution agreement with ElastiMed for the MyoSleeve wearable compression device, covering Department of Veterans Affairs and Department of Defense patients. The company paid an upfront $3 million and committed to certain minimum purchase obligations and marketing support, and the filing gives no revenue or financial outlook for the deal.
Exclusive U.S. distribution rights for MyoSleeve within the VA and DoD systems, announced July 13, 2026
Upfront payment of $3 million to ElastiMed, plus undisclosed minimum purchase and marketing commitments
MyoSleeve has FDA 510(k) clearance for chronic swelling, including chronic edema, lymphedema and venous insufficiency
SouthState Bank Corporation disclosed that James W. Roquemore, a member of its Board of Directors, died on July 9, 2026, after a long illness. The filing describes him as a long-time Board member who served from 1994 to 2020 and again from 2022 to the present, and it does not name a successor or any change to the Board's composition.
James W. Roquemore, a Board member, passed away on July 9, 2026, after a long illness.
He served on the Board from 1994 to 2020 and again from 2022 until his death.
The filing does not name a replacement director or state any change to Board committees.
Northern Oil and Gas said in a July 13, 2026 press release that it reiterated its 2026 production and capital expenditure guidance and that its board raised the share repurchase authorization by $150.0 million to about $243.0 million. The preliminary second quarter results show about 7,000 Boe per day shut in by operators, mainly in the Waha-exposed Novo assets, and an estimated $85.0 to $90.0 million in realized hedge losses, which lowers the oil production outlook for the quarter.
Estimated second quarter realized hedge losses of $85.0 to $90.0 million, partly offset by unrealized mark-to-market gains of $155.0 to $160.0 million.
About 7,000 Boe per day shut in by operators from April through part of June, mostly on Novo assets in Culberson County, TX and Eddy County, NM; second quarter oil production now expected at 67.5 to 68.25 Mbo per day.
Repurchased 2.95 million shares in the second quarter at an average price of $20.37; on July 10, 2026, the board added $150.0 million to the repurchase program.
Closed the Duvernay joint development acquisition on June 1, paying CA$237.0 million in cash and about 3.7 million common shares.
Edgewise Therapeutics completed the sale of its sevasemten muscular dystrophy program to Servier on July 10, 2026, receiving $1.55 billion in upfront cash plus up to $1.1 billion in additional milestone payments. The company says the proceeds strengthen its balance sheet and will fully fund development of its cardiovascular pipeline, led by EDG-7500, through potential approval.
Upfront cash consideration of $1.55 billion; milestone payments of up to $1.1 billion, for aggregate potential consideration of up to $2.65 billion.
Transaction completed July 10, 2026; Edgewise announced completion in a press release dated July 13, 2026.
Edgewise expects to start a Phase 3 trial of EDG-7500 in the fourth quarter of 2026 and a Phase 2 trial of EDG-15400 in HFpEF.
Edgewise intends to file pro forma financial information in a Form 8-K/A no later than four business days after completion.
Shift4 Payments disclosed that on July 8, 2026, a subsidiary entered into Amendment No. 4 to its first lien credit agreement, adding a $1.0 billion incremental senior secured term loan and extending the revolving credit facility maturity to July 8, 2031. As of July 8, 2026, outstanding term loan borrowings totaled $1,995,006,250 and revolving borrowings were $0, so the change increases the company's secured debt load while pushing out revolver maturity.
Incremental $1.0 billion senior secured term loan, fungible with existing Amendment No. 3 Refinancing Term Loans
Revolving credit facility maturity extended to July 8, 2031
Outstanding term loan borrowings of $1,995,006,250 and no revolving loans outstanding as of July 8, 2026
Proceeds to pay transaction fees and costs and for general corporate purposes
On July 12, 2026, First Hawaiian agreed to acquire TriCo Bancshares in an all-stock transaction, with TriCo shareholders receiving 2.095 First Hawaiian shares per TriCo share, valued at $63.12 per share at the July 10 closing price. The companies expect the deal to close by the end of 2026, subject to regulatory and shareholder approvals. First Hawaiian also disclosed preliminary second-quarter net income of $73.4 million and diluted EPS of $0.60, up from $67.8 million and $0.55 in the prior quarter, though these figures may change after the closing procedures and audit review.
Merger Agreement signed July 12, 2026; TriCo shareholders to receive 2.095 First Hawaiian shares per TriCo share, valued at $63.12 per share as of July 10, 2026.
Upon closing, First Hawaiian and TriCo shareholders are expected to own about 65% and 35% of the combined company; the combined company will have about $34 billion in assets.
Preliminary Q2 2026 net income of $73.4 million and diluted EPS of $0.60, compared with $67.8 million and $0.55 in the prior quarter.
Closing expected by end of 2026; final second-quarter results to be released July 24, 2026.
N-able said its Chief Revenue Officer, Frank Colletti, left the role effective July 9, 2026, and that Russell Rosa joined as Chief Revenue Officer effective immediately. Rosa will oversee the global sales organization, channel and partner ecosystem, support, and sales operations. The filing does not state any financial results or guidance changes.
Frank Colletti left his position as Chief Revenue Officer effective July 9, 2026.
Colletti may be entitled to severance under his existing employment agreement; any material changes will be disclosed in an amendment.
Russell Rosa joined as Chief Revenue Officer effective immediately, announced July 13, 2026.
Rosa's responsibilities include functions previously overseen by Colletti.
Amphastar Pharmaceuticals increased its board from 10 to 11 seats on July 9, 2026, and appointed Anthony Pierce as a Class III director, effective immediately. The board deemed him independent under Nasdaq listing standards, and he has no committee assignments at this time.
Board size increased from 10 to 11 directors; Pierce appointed effective immediately
Pierce's term runs until the 2028 annual meeting of stockholders
Annual cash retainer of $55,000, pro-rated for his start date
Initial equity grant with aggregate grant date fair value of $300,000, split 50% restricted stock units and 50% stock options, vesting on the first anniversary
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.